FAME II-10-year Follow-Up

CompletedOBSERVATIONAL
Enrollment

888

Participants

Timeline

Start Date

April 25, 2023

Primary Completion Date

May 15, 2024

Study Completion Date

May 15, 2024

Conditions
Coronary Artery Disease
Trial Locations (16)

1096

Gottsegen Hungarian Institute of Cardiology, Budapest

2100

Rigshospitalet, Copenhagen

9300

Cardiovascular Center Aalst, Aalst

30033

Atlanta VA Medical Center, Decatur

34000

Clinical Hospital Center Kragujevac, Kragujevac

44124

Azienda Ospedaliera Universitaria S. Anna (Ferrara), Cona

69500

Hopital Cardiovasculaire et Pneumologique Louis Pradel, Bron

80336

München Klinikum Innenstadt, München

94305

Stanford University Medical Center, Stanford

04401

Northern Light Eastern Maine Medical Center, Bangor

601 77

Masaryk University - Dept. of Internal Cardiology Medicine, Brno

150 00

Nemocnice Na Homolce, Prague

04289

Universität Leipzig Herzzentrum, Leipzig

5623 EJ

Catharina Ziekenhuis, Eindhoven

118 83

Sodersjukhuset, Stockholm

701 85

Universitestssjukhuset i Örebro, Örebro

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Abbott Medical Devices

INDUSTRY

lead

CoreAalst BV

INDUSTRY